Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus

American Journal of Gastroenterology

Volumn 92, Issue 3, 1997, Pages 407-413

  Weston, Allan P ^a   Krmpotich, Philip T ^b   Cherian, Rachel ^b   Dixon, Anita ^b   Topalosvki, Margaretia ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BARRETT ESOPHAGUS; BIOPSY; CARDIA; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PREVALENCE; PROSPECTIVE STUDIES; SEX FACTORS; STOMACH NEOPLASMS;

EID: 0031019728     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Haggitt RC. Barrett's esophagus dysplasia and adenocarcinoma. Hum Pathol 1994;25:982-93.
2. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37:137-43.
3. Clark GWB, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-14.
4. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
5. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barrett's esophagus: Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 1996;91:981-6.
6. Hayward J. The lower end of the esophagus. Thorax 1961;16:36-41.
7. McClave SA, Boyce HW Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: A new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413-6.
8. Bombeck CT, Dillard DH, Nyhus LM. Muscular anatomy of the gastroesophageal junction and role of phrenoesophageal ligament. Ann Surg 1966;164:643-54.
9. Gottfried MR, McClave SA, Boyce HW. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am J Clin Pathol 1989;92:741-6.
10. Hassall E. Barrett's esophagus: New definition and approach in children. J Pediatr Gastroenterol Nutr 1993;16:345-64.
11. Rubin CE, Haggitt RC, Levine DS. Endoscopic mucosal biopsy. In: Yamada T, Alpers DH, Owyang C, et al., eds. Textbook of gastroenterology. Philadelphia, PA: Lippincott, 1991: 2479-523.
12. Haggitt RC, Rubin CE. Endoscopy and endoscopic biopsy. In: Ming S-C, Goldman HE, eds. Gastrointestinal pathology. Philadelphia, PA: WB Saunders, 1992: 37-47.
13. Filipe MI. The histochemistry of intestinal mucins: Changes in disease. In: Whitehead R, ed. Gastrointestinal and oesophageal pathology, 1st ed. Edinburgh, UK: Churchill Livingstone, 1989: 65-89.
14. Filipe MI, Lake BD. Histochemistry in pathology. Edinburgh, UK: Churchill Livingstone, 1983.
15. Mowry RW. The special value of methods that color both acidic and vicinal hydroxyl groups in the histochemical study of mucins: With revised directions for the colloidal iron stain, the use of Alcian blue G8X and their combinations with periodic acid-Schiff reaction. Ann NY Acad Sci 1963;106:402-23.
16. Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1965;13:211-34.
17. Schmidt HG, Riddell RH, Walther B, et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 1985;110:145-52.
18. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical implications. Human Pathol 1983;14:931-68.
19. Blount PL, Rabinovitch PS, Reid BJ. DNA content flow cytometry and neoplastic progression in the gastrointestinal tract. In: Eastwood GL, ed. Premalignant conditions of the gastrointestinal tract: Pathogenesis, diagnosis, and management. New York, NY: Elsevier, 1990:55-77.
20. Reid BJ. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 1991;20:817-34.
21. Reid BJ, Haggitt RC, Rubin RC, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19: 166-78.
22. SAS Institute. SAS user's guide: Statistics, 6th ed. Cary, NC: SAS Institute, 1989.
23. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
24. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-9.
25. Haggitt RC, Reid BJ, Rabinovitch PS, et al. Barrett's esophagus: Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 1988;131:53-61.
26. Dent J, Bremner CG, Collen MJ, et al. Barrett's oesophagus: Working party report to world congresses of gastroenterology, Sydney, 1990. J Gastroenterol Hepatol 1991;6:1-22.
27. Haggitt RC, Dean PJ. Adenocarcinoma in Barrett's epithelium. In: Spechler SJ, Goyal R, eds. Barrett's esophagus: Pathophysiology, diagnosis, and management. New York, NY: Elsevier, 1985: 53-166.
28. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition. J Thorac Cardiovasc Surg 1975;70:826-35.
29. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315: 362-71.
30. Thompson JJ, Zinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983;14:42-61.
31. Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12.
32. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg 1983;198:554-65.
33. McArdle JE, Lewin KJ, Randall G, et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992; 23:479-82.
34. Lee RG. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients. Am J Surg Pathol 1985;9:845-52.
35. Weinstein WM, Lieberman DA, Lewin KJ, et al. Omeprazole-induced regression of Barrett's esophagus: A 2-year, randomized, controlled double blind trial. Gastroenterology 1996;110(suppl 4):A294.
36. Shaffer RT, Francis J, Carrougher JG, et al. Effect of omeprazole on Barrett's epithelium after 3 years of therapy. Gastroenterology 1996; 110(suppl 4):A255.
37. Deviere J, Buset M, Dumonceau J-M, et al. Regression of Barrett's epithelium with omeprazole. N Engl J Med 1989;320:1497-8.
38. Goldman MC, Beckman RC. Barrett syndrome: Case report with discussion about concepts of pathogenesis. Gastroenterology 1960;39: 104-10.
39. Bremner CG, Lynch VP, Ellis FH Jr. Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970;68:209-16.
40. Hage E, Pederson SA. Morphological characteristics of the columnar epithelium lining the lower oesophagus in patients with Barrett's syndrome. Virchows Arch Pathol Anat 1972;357:219-29.
41. Hamilton SR, Yardley JH. Regeneration of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977;72:669-75.
42. Qualman SJ, Murray RD, McClung HJ, et al. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990;114: 1236-40.
43. Hassall E, Weinstein WM. Partial regression of childhood Barrett's esophagus after fundoplication. Am J Gastroenterol 1992;87:1506-12.
44. Spechler SJ. Endoscopic surveillance for patients with Barrett's esophagus: Does the cancer risk justify the practice? Ann Intern Med 1987;106:902-4.
45. Riddell RH. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol 1996;91:853-63.
46. Richter JE. Endoscopic surveillance of Barrett's esophagus: Another viewpoint. Am J Gastroenterol 1993;88:630-2.
47. Spechler SJ. Barrett's esophagus. Semin Oncol 1994;21:431-7.
48. Spechler SJ, Goyal RK. Cancer surveillance in Barrett's esophagus: What is the end point? Gastroenterology 1994;106:275-6.
49. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
50. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978;70:1-5.
51. Reid BJ, Rabinovitch PS. Barrett's esophagus: A human model of genomic instability in neoplastic progression. In: Hirschowitz BI, ed. Accomplishments in oncology, vol 3. Philadelphia, PA: Lippincott, 1989.
52. Smith RRL, Boitnott JK, Hamilton SR, et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol 1984;8:563-73.
53. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987;60:1094-8.
54. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
55. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
56. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
57. Duhaylongsod FG, Wolfe WG. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 1991;102:36-42.
58. Menke-Pluymers MBE, Mulder AH, Hop WCJ, et al. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. Gut 1994;35:1348-51.
59. Krmpotich PT, Weston AP, Justice B, et al. DNA cell cycle analysis by flow cytometry of short segment Barrett's esophagus. Gastrointest Endosc 1996;43:191.
60. Ramel S, Reid BJ, Sanchez CA, et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992;102:1220-8.
61. Schneider PM, Casson AG, Levin B, et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: A prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 1996;111:323-33.
62. Jones DR, Davidson AG, Summers CL, et al. Potential application of p53 as an intermediate biomarker in Barrett's esophagus. Ann Thorac Surg 1994;57:598-603.
63. Krishnadath KK, Tilanus HW, Blankenstein M, et al. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res 1995;55:1971-6.
64. American Society for Gastrointestinal Endoscopy. Policy and procedure manual for gastrointestinal endoscopy: Guidelines for training and practice. Manchester, MA: 1990.
65. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract: Guidelines for clinical application. Gastrointest Endosc 1988;34:18S-20S.
66. Streitz JM Jr, Williamson WA, Ellis FH Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg 1992;54:586-91.
67. Kruse P, Boesby S, Bernstein IT, et al. Barrett's esophagus and esophageal adenocarcinoma: Endoscopic and histologic surveillance. Scand J Gastroenterol 1993;28:193-6.
68. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus: Does it help? J Thorac Cardiovasc Surg 1993; 105:383-8.
69. Provenzale D, Kemp JA, Arora S, et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.